Skip Navigation and Go To Content

IMM Seminar Series-May 3, 2024 (Qianben Wang, Ph.D)

Event Description

Dr. Qianben Wang, Professor of Pathology and Cell Biology, Duke Cancer Institute-Duke University School of Medicine presents “Integrated CRISPR/Cas13-based RNA editing and nanotechnology for targeting undruggable transcription and post-transcriptional vulnerabilities in lethal prostate cancer”

Event Site Link

https://www.uth.edu/imm/seminars/seminars.htm